Cyclerion Therapeutics's total assets for Q3 2025 were $10.41M, an increase of 11.15% from the previous quarter. CYCN total liabilities were $877.00K for the fiscal quarter, a 9.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.